Related references
Note: Only part of the references are listed.TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
Stephen L. Shiao et al.
CANCER IMMUNOLOGY RESEARCH (2015)
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
Yannick Bulliard et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity
William L. Redmond et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Exomics and immunogenics Bridging mutational load and immune checkpoints efficacy
Stephane Champiat et al.
ONCOIMMUNOLOGY (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
The Ratios of CD8+ T Cells to CD4+ CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
Claudia C. Preston et al.
PLOS ONE (2013)
MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
Atsuo Ochi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Transcriptional control of effector and memory CD8+ T cell differentiation
Susan M. Kaech et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
Bei Wang et al.
BREAST CANCER RESEARCH (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
Fangfang Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
Lucia De Monte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Recent Developments in Cancer Vaccines
Karolina Palucka et al.
JOURNAL OF IMMUNOLOGY (2011)
Pathogen-Induced Inflammatory Environment Controls Effector and Memory CD8+ T Cell Differentiation
Joshua J. Obar et al.
JOURNAL OF IMMUNOLOGY (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance
Virginia A. Pedicord et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
Akash Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cytotoxic effects of crystal proteins fromBacillus thuringiensisagainst breast cancer cells.
BD Tharakan et al.
CANCER RESEARCH (2010)
Combination Therapy of Established Tumors by Antibodies Targeting Immune Activating and Suppressing Molecules
Kazuyoshi Takeda et al.
JOURNAL OF IMMUNOLOGY (2010)
Cutting Edge: Lack of High Affinity Competition for Peptide in Polyclonal CD4+ Responses Unmasks IL-4 Production
Joshua D. Milner et al.
JOURNAL OF IMMUNOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Neutrophil-Derived CCL3 Is Essential for the Rapid Recruitment of Dendritic Cells to the Site of Leishmania major Inoculation in Resistant Mice
Melanie Charmoy et al.
PLOS PATHOGENS (2010)
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
William L. Redmond et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Role of OX40-Mediated Co-stimulation in T-Cell Activation and Survival
William L. Redmond et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
Activation of NF-kappa B1 by OX40 contributes to antigen-driven T cell expansion and survival
Jianxun Song et al.
JOURNAL OF IMMUNOLOGY (2008)
An IFN-γ-IL-18 Signaling Loop Accelerates Memory CD8+ T Cell Proliferation
Yoshiko Iwai et al.
PLOS ONE (2008)
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist
William L. Redmond et al.
JOURNAL OF IMMUNOLOGY (2007)
Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals
Aihua Song et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent
Luca Gattinoni et al.
BLOOD (2006)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Sergio A. Quezada et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4 T cell-dendritic cell interaction
F Castellino et al.
NATURE (2006)
Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells
JR Lees et al.
IMMUNOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dendritic cell dysfunction in cancer:: A mechanism for immunosuppression
A Pinzon-Charry et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
OX40 and Bcl-XL promote the persistence of CD8 T cells to recall tumor-associated antigen
AH Song et al.
JOURNAL OF IMMUNOLOGY (2005)
Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice
K Mahnke et al.
CANCER RESEARCH (2005)
Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion
JX Song et al.
IMMUNITY (2005)
Costimulation of CD8 T cell responses by OX40
P Bansal-Pakala et al.
JOURNAL OF IMMUNOLOGY (2004)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
PJ Kaplan-Lefko et al.
PROSTATE (2003)
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB1*0401+ patients with renal cell carcinoma or melanoma
T Tatsumi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Engagement of OX40 enhances antigen-specific CD4+ T cell mobilization/memory development and humoral immunity:: Comparison of αOX-40 with αCTLA-4
DE Evans et al.
JOURNAL OF IMMUNOLOGY (2001)
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
RPM Sutmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
DNA vaccination against rat Her-2/neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice
S Rovero et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
